CN108185140A - Pueraria lobata composite fermentation object and its preparation method and application - Google Patents
Pueraria lobata composite fermentation object and its preparation method and application Download PDFInfo
- Publication number
- CN108185140A CN108185140A CN201810086336.2A CN201810086336A CN108185140A CN 108185140 A CN108185140 A CN 108185140A CN 201810086336 A CN201810086336 A CN 201810086336A CN 108185140 A CN108185140 A CN 108185140A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- kudzu root
- preparation
- fermented product
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 109
- 230000004151 fermentation Effects 0.000 title claims abstract description 103
- 235000010575 Pueraria lobata Nutrition 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 239000002131 composite material Substances 0.000 title claims description 8
- 241000219781 Pueraria montana var. lobata Species 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 59
- 239000003814 drug Substances 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 230000001142 anti-diarrhea Effects 0.000 claims abstract description 11
- 238000000926 separation method Methods 0.000 claims abstract description 11
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 10
- 239000001963 growth medium Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000011550 stock solution Substances 0.000 claims abstract description 8
- 244000046146 Pueraria lobata Species 0.000 claims description 68
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 36
- 239000000843 powder Substances 0.000 claims description 30
- 244000197580 Poria cocos Species 0.000 claims description 29
- 235000008599 Poria cocos Nutrition 0.000 claims description 29
- 241000219780 Pueraria Species 0.000 claims description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 21
- 235000006533 astragalus Nutrition 0.000 claims description 20
- 241001061264 Astragalus Species 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 19
- 210000004233 talus Anatomy 0.000 claims description 19
- 239000004310 lactic acid Substances 0.000 claims description 18
- 235000014655 lactic acid Nutrition 0.000 claims description 18
- 239000007900 aqueous suspension Substances 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 13
- 102000004142 Trypsin Human genes 0.000 claims description 12
- 108090000631 Trypsin Proteins 0.000 claims description 12
- 239000012588 trypsin Substances 0.000 claims description 12
- 108010059892 Cellulase Proteins 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 108010059820 Polygalacturonase Proteins 0.000 claims description 11
- 229940106157 cellulase Drugs 0.000 claims description 11
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 11
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- 229940041514 candida albicans extract Drugs 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 7
- 239000012138 yeast extract Substances 0.000 claims description 7
- 150000003863 ammonium salts Chemical class 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 6
- 159000000003 magnesium salts Chemical class 0.000 claims description 6
- 230000003068 static effect Effects 0.000 claims description 6
- 150000003751 zinc Chemical class 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 5
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 12
- 239000004480 active ingredient Substances 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
- 102000004190 Enzymes Human genes 0.000 description 23
- 108090000790 Enzymes Proteins 0.000 description 23
- 229940088598 enzyme Drugs 0.000 description 23
- 206010012735 Diarrhoea Diseases 0.000 description 22
- 230000000694 effects Effects 0.000 description 22
- 239000000284 extract Substances 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 230000007071 enzymatic hydrolysis Effects 0.000 description 8
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 6
- 235000019796 monopotassium phosphate Nutrition 0.000 description 6
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 6
- 239000003674 animal food additive Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 235000007240 daidzein Nutrition 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 239000011592 zinc chloride Substances 0.000 description 4
- 235000005074 zinc chloride Nutrition 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000194020 Streptococcus thermophilus Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- 241000748223 Alisma Species 0.000 description 2
- 241000132012 Atractylodes Species 0.000 description 2
- 244000025596 Cassia laevigata Species 0.000 description 2
- 235000006693 Cassia laevigata Nutrition 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 229930186706 Puerarin-xyloside Natural products 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940107666 astragalus root Drugs 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 229960002261 magnesium phosphate Drugs 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940124513 senna glycoside Drugs 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 241000605447 Anemarrhena Species 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000207901 Cuscuta Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229930191283 anemarrhena Natural products 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000011224 negative regulation of urine volume Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000008575 shengdi Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Sustainable Development (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种葛根复合发酵物及其制备方法和用途。使用含葛根复合酶解物的培养基进行三次不同条件的发酵,然后将所得发酵物进行固液分离得到发酵原液,即为葛根复合发酵物。本发明的制备方法发酵时间短,从而更加有利于工业化生产。此外,本发明的发酵方式还可改善所得发酵物中的活性成分,显著改善药效,特别是抗腹泻效果。The invention discloses a kudzu root compound fermented product, a preparation method and application thereof. The culture medium containing the kudzu root compound enzymatic hydrolyzate is used for three fermentations under different conditions, and then the fermented product is subjected to solid-liquid separation to obtain a fermentation stock solution, which is the kudzu root compound fermented product. The preparation method of the invention has a short fermentation time, thereby being more favorable for industrialized production. In addition, the fermentation method of the present invention can also improve the active ingredients in the obtained fermented product, and significantly improve the drug efficacy, especially the antidiarrheal effect.
Description
技术领域technical field
本发明涉及一种葛根复合发酵物及其制备方法和用途,尤其是一种具有抗腹泻作用的葛根复合发酵物及其制备方法和用途。The invention relates to a kudzu root compound fermented product and its preparation method and application, in particular to a kudzu root compound fermented product with anti-diarrhea effect, its preparation method and application.
背景技术Background technique
葛根含异黄酮成分葛根素、葛根素木糖甙、大豆黄酮、大豆黄酮甙及β-谷甾醇、花生酸,又含大量淀粉。葛根用于治疗表证发热、项背强痛、麻疹不透、热病口渴、阴虚消渴、热泻热痢、脾虚泄泻。Puerarin contains isoflavone components puerarin, puerarin xyloside, daidzein, daidzein, β-sitosterol, arachidic acid, and a large amount of starch. Radix Puerariae is used to treat superficial syndromes of fever, strong pain in the nape and back, opaque measles, fever and thirst, yin deficiency and thirst, heat diarrhea and dysentery, and diarrhea due to spleen deficiency.
为了深入开发利用中药资源,近年来已进行了中药发酵技术的研究。例如,CN104606487A公开了一种发酵中药制剂,其中中药原料为泽泻、天花粉、黄连、党参、葛根、黄精、黄芪、黄柏、苦瓜、枸杞子、五味子、灵芝、茯苓、地龙、山药、苍术、僵蚕、猪苓、白术、知母。该文献中提供的发酵中药制剂在治疗、治愈糖尿病方面有很好的效果。In order to further develop and utilize traditional Chinese medicine resources, research on traditional Chinese medicine fermentation technology has been carried out in recent years. For example, CN104606487A discloses a fermented Chinese medicine preparation, wherein the raw materials of the Chinese medicine are Alisma, Trichosanthes, Coptidis, Codonopsis, Pueraria, Rhizoma Polygonatum, Astragalus, Cortex Phellodendron, Bitter Gourd, Lycium barbarum, Schisandra, Ganoderma lucidum, Poria, Earthworm, Chinese yam, Atractylodes atractylodes, Silkworm, Polyporus, Atractylodes Rhizoma, Anemarrhena. The fermented Chinese medicine preparation provided in this document has good effects in treating and curing diabetes.
再如,CN106306512 A公开了一种治疗猪腹泻的发酵中草药饲料添加剂,中草药为葛根、野菊花、金银花、知母、女贞子、黄芪、延胡索、厚朴、银杏叶、地榆、石菖蒲、制何首乌、生地、十大功劳、紫花地丁、仙鹤草、菟丝子、玄参、徐长卿、茯苓、柴胡、丁香和泽泻。该添加剂具有很强的动物抗病性、促进动物生长、提高成活率高、减低腹泻率的作用。For another example, CN106306512 A discloses a fermented Chinese herbal medicine feed additive for the treatment of swine diarrhea. Prepare Polygonum multiflorum, Shengdi, Ten Great Merits, Viola, Agrimony, Cuscuta, Scrophulariae, Xu Changqing, Poria, Bupleurum, Clove and Alisma. The additive has strong animal disease resistance, promotes animal growth, improves survival rate and reduces diarrhea rate.
虽然上述文献均针对含葛根的复方进行了发酵研究,但是这些技术中或者原料成分复杂或者抗腹泻疗效不足。Although the above-mentioned literatures have all carried out fermentation research on compound recipes containing Pueraria lobata, these technologies either have complex raw material components or insufficient antidiarrheal efficacy.
因此,如何进一步开发利用葛根资源,提高葛根利用率是一个值得研究的课题。Therefore, how to further develop and utilize Puerariae resources and improve the utilization rate of Puerariae is a subject worth studying.
发明内容Contents of the invention
本发明的目的在于提供一种葛根复合发酵物或葛根复合发酵干粉的制备方法,该方法可以仅使用三种中药原料进行发酵,发酵时间短,并且所得发酵物药效大大提升。本发明的另一目的在于提供一种葛根复合发酵产品,具有改善的抗腹泻作用。本发明的再一目的在于上述葛根复合发酵产品的用途。本发明的目的是通过如下技术方案实现的。The object of the present invention is to provide a preparation method of kudzu root compound fermented product or kudzu root compound fermented dry powder, which can use only three kinds of traditional Chinese medicine raw materials for fermentation, the fermentation time is short, and the medicinal effect of the obtained fermented product is greatly improved. Another object of the present invention is to provide a compound fermented product of kudzu root, which has improved antidiarrheal effect. Another object of the present invention is the use of the above-mentioned kudzu root compound fermentation product. The purpose of the present invention is achieved through the following technical solutions.
本发明的第一方面,提供一种葛根复合发酵物的制备方法,其包括以下步骤:The first aspect of the present invention provides a preparation method of kudzu root compound fermented product, which comprises the following steps:
第一发酵步骤:利用酵母菌在26~32℃下在培养基中进行厌氧发酵10~20h,得到第一发酵物,其中所述培养基包含葛根复合酶解物;The first fermentation step: using yeast to carry out anaerobic fermentation in the medium at 26-32°C for 10-20 hours to obtain the first fermented product, wherein the medium contains kudzu root compound enzymatic hydrolyzate;
第二发酵步骤:将第一发酵物的温度升至33~40℃,并在该温度下利用乳酸菌进行静置发酵30~40h,得到第二发酵物;The second fermentation step: raising the temperature of the first fermented product to 33-40°C, and using lactic acid bacteria to carry out static fermentation at this temperature for 30-40 hours to obtain the second fermented product;
第三发酵步骤:将第二发酵物的温度升至50~70℃,并在该温度下静置发酵25~35h,得到第三发酵物;The third fermentation step: raising the temperature of the second fermented product to 50-70° C., and standing and fermenting at this temperature for 25-35 hours to obtain the third fermented product;
固液分离步骤:将所得第三发酵物进行固液分离得到发酵原液,即为葛根复合发酵物。Solid-liquid separation step: the obtained third fermented product is subjected to solid-liquid separation to obtain a fermentation stock solution, which is a kudzu root compound fermented product.
根据本发明所述的制备方法,优选地,所述葛根复合酶解物通过使用果胶酶、纤维素酶、木聚糖酶和胰蛋白酶在6.0~7.2的pH值和45~60℃的温度下酶解含葛根、黄芪和茯苓的水悬浮液2~6h制得。According to the preparation method of the present invention, preferably, the kudzu root compound enzymatic hydrolyzate is obtained by using pectinase, cellulase, xylanase and trypsin at a pH value of 6.0-7.2 and a temperature of 45-60°C. It is obtained by enzymatically hydrolyzing the aqueous suspension containing kudzu root, astragalus and poria cocos for 2 to 6 hours.
根据本发明所述的制备方法,优选地,所述果胶酶的用量为水悬浮液总重量的0.05~0.3wt%,所述纤维素酶的用量为水悬浮液总重量的0.05~0.3wt%,木聚糖酶的用量为水悬浮液总重量的0.05~0.3wt%,和所述胰蛋白酶的用量为水悬浮液总重量的0.05~0.15wt%。According to the preparation method of the present invention, preferably, the dosage of the pectinase is 0.05-0.3wt% of the total weight of the aqueous suspension, and the dosage of the cellulase is 0.05-0.3wt% of the total weight of the aqueous suspension %, the dosage of xylanase is 0.05-0.3wt% of the total weight of the aqueous suspension, and the dosage of the trypsin is 0.05-0.15wt% of the total weight of the aqueous suspension.
根据本发明所述的制备方法,优选地,果胶酶、纤维素酶、木聚糖酶和胰蛋白酶的重量比为1:1:1:1。According to the preparation method of the present invention, preferably, the weight ratio of pectinase, cellulase, xylanase and trypsin is 1:1:1:1.
根据本发明所述的制备方法,优选地,在所述含葛根、黄芪和茯苓的水悬浮液中,葛根为30~55重量份、黄芪为30~40重量份、茯苓为10~20重量份,且葛根的含量大于黄芪的含量。According to the preparation method of the present invention, preferably, in the aqueous suspension containing Pueraria Radix, Radix Astragali and Poria Cocos, 30-55 parts by weight of Pueraria Radix, 30-40 parts by weight of Radix Astragali, and 10-20 parts by weight of Poria Cocos , and the content of kudzu root is greater than that of astragalus.
根据本发明所述的制备方法,优选地,所述培养基进一步包含0.1~0.5wt%酵母膏、1~5wt%铵盐、0.01~0.2wt%镁盐、0.3~0.8wt%磷酸盐和0.01~0.2wt%的锌盐;以上重量百分数均是基于所述培养基的总重量。According to the preparation method of the present invention, preferably, the medium further comprises 0.1-0.5wt% yeast extract, 1-5wt% ammonium salt, 0.01-0.2wt% magnesium salt, 0.3-0.8wt% phosphate and 0.01 -0.2 wt% zinc salt; the above weight percentages are based on the total weight of the culture medium.
根据本发明所述的制备方法,优选地,第一发酵步骤中所述酵母菌的接种量为每ml所述培养基1×107cfu~9×107cfu,第二发酵步骤中所述乳酸菌的接种量为每ml所述培养基1×106cfu~9×106cfu。According to the preparation method of the present invention, preferably, the inoculum amount of the yeast in the first fermentation step is 1×10 7 cfu to 9×10 7 cfu per ml of the medium, and the yeast in the second fermentation step The inoculum amount of lactic acid bacteria is 1×10 6 cfu to 9×10 6 cfu per ml of the culture medium.
本发明的第二方面,提供一种葛根复合发酵干粉的制备方法,其包括采用本发明第一方面所述的制备方法获得葛根复合发酵物,然后将所述葛根复合发酵物进行浓缩干燥制得发酵干粉。The second aspect of the present invention provides a method for preparing kudzu root compound fermented dry powder, which comprises adopting the preparation method described in the first aspect of the present invention to obtain a kudzu root compound fermented product, and then concentrating and drying the kudzu root compound fermented product to obtain Fermented dry powder.
本发明的第三方面,提供一种葛根复合发酵产品,其为根据本发明第一方面所述制备方法获得的葛根复合发酵物或者本发明第二方面所述制备方法获得的葛根复合发酵干粉。The third aspect of the present invention provides a kudzu root compound fermented product, which is the kudzu root compound fermented product obtained according to the preparation method described in the first aspect of the present invention or the kudzu root compound fermented dry powder obtained by the preparation method described in the second aspect of the present invention.
本发明的第四方面,提供本发明的葛根复合发酵产品在制备具有抗腹泻作用的药物、食品或饲料中的用途。The fourth aspect of the present invention provides the use of the kudzu root compound fermentation product of the present invention in the preparation of medicine, food or feed with antidiarrheal effect.
本发明通过采用酶解结合三次强化发酵的方式,使得发酵时间减少,从而更加有利于工业化生产。此外,本发明的强化发酵还可改善所得发酵物中的活性成分,显著改善药效,特别是抗腹泻效果。The invention reduces the fermentation time by adopting the method of enzymatic hydrolysis combined with three times of intensified fermentation, thereby being more conducive to industrial production. In addition, the enhanced fermentation of the present invention can also improve the active ingredients in the obtained fermented product, and significantly improve the drug efficacy, especially the antidiarrheal effect.
具体实施方式Detailed ways
下面结合具体实施例对本发明作进一步的说明,但本发明的保护范围并不限于此。The present invention will be further described below in conjunction with specific examples, but the protection scope of the present invention is not limited thereto.
本发明所述的“葛根复合发酵物”是指利用包含葛根的复方中药进行生物发酵制备得到的发酵物,本文有时也称作为“葛根复合酵素”,或简称为“复合发酵物”或“复合酵素”。The "pueraria compound fermented product" described in the present invention refers to a fermented product prepared by biological fermentation using a compound Chinese medicine containing pueraria root, and is sometimes referred to herein as "pueraria root compound enzyme", or simply referred to as "composite fermented product" or "composite fermented product". Enzyme".
本发明针对利用葛根治疗腹泻时药效不高的问题,提出了基于酶解葛根复方中药成分,并结合三次发酵进行强化处理的方案,并基于该方案完成了本发明。具体地,本发明包括以下内容。Aiming at the problem of low drug efficacy when using Pueraria root to treat diarrhea, the present invention proposes a plan based on enzymatic hydrolysis of Pueraria root compound traditional Chinese medicine components, combined with three times of fermentation for intensive treatment, and completes the present invention based on this plan. Specifically, the present invention includes the following contents.
本发明的第一方面,提供一种葛根复合发酵物的制备方法,其包括三次发酵步骤和固液分离步骤。下面详细说明各步骤。The first aspect of the present invention provides a method for preparing a kudzu root compound fermentation product, which includes three fermentation steps and a solid-liquid separation step. Each step is described in detail below.
<第一发酵步骤><First fermentation step>
第一发酵步骤为酵母菌厌氧发酵步骤,包括利用酵母菌在26~32℃下在培养基中进行厌氧发酵10~20h,得到第一发酵物,其中所述培养基包含葛根复合酶解物。The first fermentation step is the anaerobic fermentation step of yeast, including using yeast to carry out anaerobic fermentation in the medium at 26-32°C for 10-20 hours to obtain the first fermented product, wherein the medium contains kudzu root compound enzymatic hydrolysis things.
利用酵母菌在厌氧条件下对葛根复合酶解物进行发酵可产生对肠道有益菌增殖有促进作用的有效代谢产物。第一发酵中酵母菌的接种量为每ml所述培养基1×107cfu~9×107cfu,优选1.5×107cfu~7×107cfu,更优选3×107cfu~6×107cfu。酵母菌可采用本领域已知的任何菌种,不特别特定。优选由安琪酵母股份有限公司生产的高活性干酵母,该菌种对于葛根有效成分的生物学转化特别有利。Using yeast to ferment kudzu root compound enzymatic hydrolyzate under anaerobic conditions can produce effective metabolites that can promote the proliferation of beneficial intestinal bacteria. The inoculation amount of yeast in the first fermentation is 1×10 7 cfu~9×10 7 cfu per ml of the culture medium, preferably 1.5×10 7 cfu~7×10 7 cfu, more preferably 3×10 7 cfu~6 ×10 7 cfu. As the yeast, any strain known in the art can be used, and it is not particularly specified. Highly active dry yeast produced by Angel Yeast Co., Ltd. is preferred, and this strain is particularly beneficial for the biological transformation of the active ingredients of kudzu root.
第一发酵的发酵温度为26~32℃,优选为27~31℃,更优选为28℃,此温度范围一方面有利于酵母菌的发酵,并且还有利于葛根有效成分的生物学转化。如果第一发酵温度过高,则会影响酵母菌的活性。The fermentation temperature of the first fermentation is 26-32°C, preferably 27-31°C, more preferably 28°C. This temperature range is beneficial to the fermentation of yeast and the biological transformation of the active ingredients of kudzu root. If the first fermentation temperature is too high, it will affect the activity of yeast.
第一发酵的发酵时间为10~20h,优选为11~18h,更优选为16h。此发酵时间可以使得酵母菌的作用充分发挥,所得发酵物中高活性成分含量高。The fermentation time of the first fermentation is 10-20 h, preferably 11-18 h, more preferably 16 h. This fermentation time can make the effect of the yeast fully exerted, and the content of high active ingredients in the obtained fermented product is high.
第一发酵步骤中的培养基需包含葛根复合酶解物。葛根复合酶解物为通过酶处理使有利于发酵的成分释放或不利于发酵的成分分解后的酶处理物。优选地,葛根复合酶解物为通过使用果胶酶、纤维素酶、木聚糖酶和胰蛋白酶的组合处理葛根复方药材得到的混合物。四种酶可在本申请所述条件下同时高效作用,促进酶解,且酶活性之间不存在不利影响。The culture medium in the first fermentation step needs to contain the complex hydrolyzate of kudzu root. The kudzu root compound enzymatic hydrolyzate is an enzyme-treated product after enzyme treatment releases components that are beneficial to fermentation or decomposes components that are not conducive to fermentation. Preferably, the kudzu root compound enzymatic hydrolyzate is a mixture obtained by treating the kudzu root compound medicinal material with a combination of pectinase, cellulase, xylanase and trypsin. The four enzymes can act simultaneously and efficiently under the conditions described in this application to promote enzymolysis, and there is no adverse effect among the enzyme activities.
葛根复方药材包含葛根及其他中药,其他中药优选为黄芪和/或茯苓。葛根复方药材为葛根、黄芪和茯苓的组合。根据本发明的一个实施方式,葛根复方药材仅由葛根、黄芪和茯苓组成。The kudzu root compound medicinal material includes kudzu root and other traditional Chinese medicines, and the other traditional Chinese medicines are preferably astragalus and/or poria cocos. Pueraria root compound medicinal material is the combination of Pueraria root, Radix Astragali and Poria cocos. According to one embodiment of the present invention, the Pueraria root compound medicinal material only consists of Pueraria root, Radix Astragali and Poria cocos.
在本发明中,葛根(Pueraria lobata(Willd.)ohwi)含异黄酮成分葛根素、葛根素木糖甙、大豆黄酮、大豆黄酮甙及β-谷甾醇、花生酸,又含大量淀粉。传统中医中将其用于表证发热、项背强痛、麻疹不透、热病口渴、阴虚消渴、热泻热痢、脾虚泄泻。本发明通过以葛根为君药,合理配伍,增强其脾虚泄泻。In the present invention, Pueraria lobata (Willd.) ohwi contains isoflavone components puerarin, puerarin xyloside, daidzein, daidzein, β-sitosterol, arachidic acid, and a large amount of starch. In traditional Chinese medicine, it is used for superficial fever, stiff neck and back pain, opaque measles, fever and thirst, yin deficiency and thirst, heat diarrhea and dysentery, and diarrhea due to spleen deficiency. The present invention strengthens spleen-deficiency diarrhea by using kudzu root as the monarch drug and rational compatibility.
在本发明中,黄芪(Astragalus membranaceus(Fisch.)Bunge.)含皂甙、蔗糖、多糖、多种氨基酸、叶酸及硒、锌、铜等多种微量元素。传统中医认为黄芪的功效有益气固表、利水消肿、脱毒、生肌的功效,适用于自汗、盗汗、血痹、浮肿、痈疽不溃或溃久不敛等症。本发明中黄芪可任意选择,不特别限定。优选蜜炙黄芪,因为其与葛根更能增益互补,提高药效。In the present invention, Astragalus membranaceus (Fisch.) Bunge.) contains saponins, sucrose, polysaccharides, various amino acids, folic acid, selenium, zinc, copper and other trace elements. Traditional Chinese medicine believes that the effects of Astragalus are beneficial to Qi consolidation, diuresis, detumescence, detoxification, and muscle growth. Astragalus in the present invention can be selected arbitrarily and is not particularly limited. Honey-roasted Radix Astragalus is preferred, because it can complement Pueraria radix more effectively and improve the medicinal effect.
在本发明中,茯苓(Poria cocos(Schw.)Wolf)含茯苓多糖、B-茯苓聚糖、茯苓酸、卵磷脂及甾醇等。传统中医认为其具有败毒抗癌、利水化饮、健脾化痰、宁心安神的功效。In the present invention, Poria cocos (Poria cocos (Schw.) Wolf) contains pachyan, B-pachyan, pachynic acid, lecithin, sterol, and the like. Traditional Chinese medicine believes that it has the effects of detoxifying and anti-cancer, diuresis and drinking, invigorating the spleen and reducing phlegm, calming the mind and calming the nerves.
三种药材中以黄芪为臣,佐君葛根,再辅以茯苓应臣,君臣佐使合理配伍,相与宣摄,御脾虚、止泄泻。优选地,葛根为30~55重量份,优选35~50重量份;黄芪为30~40重量份,优选32~48重量份;茯苓为10~20重量份,优选为12~18重量份。本发明中优选葛根的含量大于黄芪的含量。在发酵时三种药材的组合能够协同作用,抗腹泻效果更优。Among the three kinds of medicinal materials, Astragalus is used as the minister, and Puerariae root is used to assist the monarch, and Poria cocos is used as the minister. The monarch, minister and assistant envoy are reasonably compatible. Preferably, Pueraria root is 30-55 parts by weight, preferably 35-50 parts by weight; Astragalus is 30-40 parts by weight, preferably 32-48 parts by weight; Poria cocos is 10-20 parts by weight, preferably 12-18 parts by weight. In the present invention, the content of kudzu root is preferably greater than that of astragalus. The combination of the three medicinal materials can act synergistically during fermentation, and the antidiarrheal effect is better.
本发明所述的酶处理(本文有时亦称作“酶解”)的条件不特别限定,例如,可以在6.0~7.2的pH值和45~60℃的温度下酶解含所述复方药的水悬浮液2~6h。优选地,酶处理的pH值为6.5~6.9,更优选6.8,此pH值范围可保证本发明的各种酶同时保持高活性。优选地,酶处理的温度为50~60℃,更优选50℃。本发明中的酶需耐受较高温度的酶,因为过低的酶解温度不利于抗腹泻成分的释放。酶处理时间优选为3~5小时,例如4.5小时。The conditions of the enzyme treatment (sometimes referred to herein as "enzyme hydrolysis") of the present invention are not particularly limited, for example, the enzyme containing the compound drug can be enzymatically hydrolyzed at a pH value of 6.0 to 7.2 and a temperature of 45 to 60°C. Water suspension 2 ~ 6h. Preferably, the pH value of the enzyme treatment is 6.5-6.9, more preferably 6.8, and this pH value range can ensure that various enzymes of the present invention maintain high activity at the same time. Preferably, the enzyme treatment temperature is 50-60°C, more preferably 50°C. The enzyme in the present invention needs to be resistant to higher temperature, because too low enzymatic hydrolysis temperature is not conducive to the release of antidiarrheal components. The enzyme treatment time is preferably 3 to 5 hours, for example, 4.5 hours.
酶处理时果胶酶、纤维素酶、木聚糖酶和胰蛋白酶的用量,基于悬浮液的总重量,可分别为0.05~0.3wt%。优选分别为0.06~0.2wt%,更优选分别为0.08~0.15wt%,还优选分别为0.1~0.12wt%,胰蛋白酶的用量可以为0.03~0.2wt%,优选为0.05~0.15wt%,更优选为0.1~0.15wt%。四种酶的组合为发酵培养提供氨基酸、单糖、寡糖以及其他有益成分等原料。酶的重量比不特别特定,例如,果胶酶、纤维素酶、木聚糖酶和胰蛋白酶的重量比可为1:1:1:1。The amounts of pectinase, cellulase, xylanase and trypsin used in the enzyme treatment may be 0.05-0.3 wt%, based on the total weight of the suspension. Preferably respectively 0.06~0.2wt%, more preferably respectively 0.08~0.15wt%, also preferably respectively respectively 0.1~0.12wt%, the consumption of trypsin can be 0.03~0.2wt%, preferably 0.05~0.15wt%, more Preferably it is 0.1 to 0.15 wt%. The combination of four enzymes provides raw materials such as amino acids, monosaccharides, oligosaccharides and other beneficial ingredients for fermentation culture. The weight ratio of enzymes is not particularly specific, for example, the weight ratio of pectinase, cellulase, xylanase and trypsin may be 1:1:1:1.
用于酶处理的葛根复方药材中各药材可分别为全草或根部,对此并不特别限定。优选地,用于酶处理的葛根、黄芪和茯苓均为粉末,粉末的细度不特别限定,优选较细的粉末,从而更有利于酶解的进行。优选地,将上述三种粉末与水混合制备水悬浮液,将其用于酶处理。其中三种粉末的总重量与水的重量比不特别限定,优选1:5~15,例如,1:10。水可使用纯水、去离子水和蒸馏水。水的pH优选为6.0~6.5,此pH范围内的水更有利于酶解的进行。Each medicinal material in the kudzu root compound medicinal material used for the enzyme treatment may be the whole plant or the root, which is not particularly limited. Preferably, the kudzu root, astragalus root, and poria cocos used for the enzyme treatment are all powders, and the fineness of the powders is not particularly limited, and finer powders are preferred, so as to facilitate the enzymatic hydrolysis. Preferably, the above three powders are mixed with water to prepare an aqueous suspension, which is used for enzyme treatment. The weight ratio of the total weight of the three powders to water is not particularly limited, preferably 1:5-15, for example, 1:10. As water, pure water, deionized water and distilled water can be used. The pH of the water is preferably 6.0-6.5, and water within this pH range is more conducive to enzymatic hydrolysis.
第一发酵步骤中的培养基还可包含营养物质。优选地,营养物质可选自酵母膏、铵盐、锌盐、镁盐和磷酸盐中的至少一种成分。基于培养基的总重量,培养基可包含0.1~0.5wt%酵母膏、1~5wt%铵盐、0.01~0.2wt%镁盐、0.3~0.8wt%磷酸盐和0.01~0.2wt%的锌盐。可以采用市售的酵母膏。酵母膏的用量优选为0.2~0.3wt%。铵盐可以选自硫酸铵、硝酸铵或碳酸铵中的至少一种,优选为硫酸铵。铵盐的用量优选为1.5~3.5wt%,更优选为1.5~2.5wt%。镁盐可以选自硫酸镁、氯化镁、硝酸镁、碳酸镁中的至少一种,优选为硫酸镁。镁盐的用量优选为0.03~0.15wt%,更优选为0.05~0.1wt%。磷酸盐可以选自磷酸钠、磷酸氢二钠、磷酸二氢钠、磷酸钾、磷酸氢二钾、磷酸二氢钾、磷酸钙、磷酸镁中的至少一种,优选为磷酸二氢钾。磷酸盐的用量优选为0.35~0.65wt%,更优选为0.35~0.5wt%。锌盐可以选自硫酸锌、氯化锌、硝酸锌中的至少一种,并优选为氯化锌。所述营养物质可以包括0.03~0.2wt%、优选为0.05~0.15wt%、更优选为0.08~0.1wt%的锌盐。上述范围内的营养物质及比例,更有利于满足酵母菌、乳酸菌的发酵培养的营养元素需求,并且可以减少发酵时间。The medium in the first fermentation step may also contain nutrients. Preferably, the nutrient may be selected from at least one component selected from yeast extract, ammonium salt, zinc salt, magnesium salt and phosphate. Based on the total weight of the medium, the medium may contain 0.1-0.5wt% yeast extract, 1-5wt% ammonium salt, 0.01-0.2wt% magnesium salt, 0.3-0.8wt% phosphate and 0.01-0.2wt% zinc salt . Commercially available yeast paste can be used. The dosage of yeast extract is preferably 0.2-0.3 wt%. The ammonium salt can be selected from at least one of ammonium sulfate, ammonium nitrate or ammonium carbonate, preferably ammonium sulfate. The amount of ammonium salt used is preferably 1.5-3.5 wt%, more preferably 1.5-2.5 wt%. The magnesium salt may be selected from at least one of magnesium sulfate, magnesium chloride, magnesium nitrate, and magnesium carbonate, preferably magnesium sulfate. The dosage of the magnesium salt is preferably 0.03-0.15 wt%, more preferably 0.05-0.1 wt%. Phosphate may be selected from at least one of sodium phosphate, disodium hydrogen phosphate, sodium dihydrogen phosphate, potassium phosphate, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, calcium phosphate, and magnesium phosphate, preferably potassium dihydrogen phosphate. The amount of phosphate used is preferably 0.35-0.65 wt%, more preferably 0.35-0.5 wt%. The zinc salt can be selected from at least one of zinc sulfate, zinc chloride, and zinc nitrate, and is preferably zinc chloride. The nutrient may include 0.03-0.2wt%, preferably 0.05-0.15wt%, more preferably 0.08-0.1wt% of zinc salt. Nutrients and ratios within the above range are more conducive to meeting the nutrient element requirements for the fermentation and cultivation of yeast and lactic acid bacteria, and can reduce the fermentation time.
本发明的营养物质还可以含有钾盐。该钾盐与磷酸盐优选为同一物质,例如磷酸钾、磷酸氢二钾或磷酸二氢钾,优选为磷酸二氢钾。The nutritional substances of the present invention may also contain potassium salts. The potassium salt and the phosphate are preferably the same substance, such as potassium phosphate, dipotassium hydrogenphosphate or potassium dihydrogenphosphate, preferably potassium dihydrogenphosphate.
<第二发酵步骤><Second Fermentation Step>
第二发酵步骤为添加乳酸菌进行强化发酵的步骤,包括将第一发酵物的温度升至33~40℃,并在该温度下利用乳酸菌进行静置发酵30~40h,得到第二发酵物。第二发酵物为强化发酵物或强化酵素。其不仅具有普通酵素的通用功能,而且效力特别是针对腹泻的效力更强。The second fermentation step is a step of adding lactic acid bacteria for intensified fermentation, including raising the temperature of the first fermented product to 33-40° C., and using lactic acid bacteria for static fermentation at this temperature for 30-40 hours to obtain the second fermented product. The second fermented product is an enhanced fermented product or an enhanced enzyme. It not only has the general function of ordinary enzymes, but also has stronger potency especially against diarrhea.
本发明的乳酸菌可以选自保加利亚乳杆菌和嗜热链球菌的一种或多种,优选为保加利亚乳杆菌和嗜热链球菌的混合物。保加利亚乳杆菌和嗜热链球菌的重量比可以为1:10~10:1,优选为1:5~5:1,更优选为1:1。乳酸菌的接种量为每ml所述培养基1×106cfu~9×106cfu,优选2×106cfu~8×106cfu,更优选5×106cfu~8×106cfu。乳酸菌的接种量需大于第一发酵时酵母菌的接种量。如果乳酸菌的接种量过低,则第一发酵时酵母菌的量相对过多,影响乳酸菌的增殖,进而影响发酵物的强化效果。The lactic acid bacteria of the present invention can be selected from one or more of Lactobacillus bulgaricus and Streptococcus thermophilus, preferably a mixture of Lactobacillus bulgaricus and Streptococcus thermophilus. The weight ratio of Lactobacillus bulgaricus and Streptococcus thermophilus can be 1:10-10:1, preferably 1:5-5:1, more preferably 1:1. The inoculation amount of lactic acid bacteria is 1×10 6 cfu to 9×10 6 cfu per ml of the culture medium, preferably 2×10 6 cfu to 8×10 6 cfu, more preferably 5×10 6 cfu to 8×10 6 cfu. The inoculum of lactic acid bacteria needs to be greater than the inoculum of saccharomyces during the first fermentation. If the inoculum amount of lactic acid bacteria is too low, the amount of yeast in the first fermentation will be relatively too much, which will affect the proliferation of lactic acid bacteria and further affect the strengthening effect of the fermented product.
第二发酵步骤的温度需高于第一发酵步骤的温度,优选在33~40℃范围内,更优选35~39℃,进一步更优选37℃。这样的温度接近人体环境温度,模拟乳酸菌在人体内的作用温度,从而转化生成或从中药释放的活性成分更有利于人体吸收。The temperature of the second fermentation step needs to be higher than the temperature of the first fermentation step, preferably in the range of 33-40°C, more preferably 35-39°C, even more preferably 37°C. Such a temperature is close to the ambient temperature of the human body, simulating the action temperature of lactic acid bacteria in the human body, so that the active ingredients transformed or released from traditional Chinese medicine are more conducive to the absorption of the human body.
第二发酵的时间不特别限定,通常情况下为30~40h,优选为35~39h,更优选为32h。发酵时间过长,生物转化的速率会变得下降,同时可生成其他副产物,这些副产物不利于药效的发挥。另一方面,如果发酵时间过短,则反应不充分,部分药物有效成分尚未生成,从而使所得发酵物的药效降低,并且可造成资源浪费。The time for the second fermentation is not particularly limited, and is generally 30-40 hours, preferably 35-39 hours, more preferably 32 hours. If the fermentation time is too long, the rate of biotransformation will decrease, and other by-products can be generated at the same time, which are not conducive to the efficacy of the drug. On the other hand, if the fermentation time is too short, the reaction will not be sufficient, and some active ingredients of the medicine will not be produced, so that the medicine effect of the obtained fermented product will be reduced, and resources will be wasted.
第二发酵需静置发酵。静置发酵更类似于体内益生菌群的环境,因而是优选的。The second fermentation needs static fermentation. Static fermentation is more similar to the environment of the probiotic flora in the body, so it is preferred.
<第三发酵步骤><The third fermentation step>
第三发酵步骤是酵母菌和乳酸菌双菌高温发酵的步骤,包括将第二发酵物的温度升至50~70℃,并在该温度下静置发酵25~35h,得到第三发酵物。The third fermentation step is a high-temperature fermentation step of yeast and lactic acid bacteria, which includes raising the temperature of the second fermented product to 50-70° C., and standing and fermenting at this temperature for 25-35 hours to obtain the third fermented product.
通过在50~70℃下使酵母菌和乳酸菌同时进行继续发酵,可更有效地促进有效成分的含量在短时间内快速产生。第二发酵温度的范围优选55~65℃,更优选65℃。在该温度下,仅静置发酵20~35h,优选21~32h,更优选26~30h便可得到具有所需性能的第三发酵物,大大缩短了传统方法中的发酵时间。By making yeast and lactic acid bacteria continue to ferment simultaneously at 50-70° C., the content of active ingredients can be more effectively promoted to be rapidly produced in a short time. The range of the second fermentation temperature is preferably 55-65°C, more preferably 65°C. At this temperature, the third fermented product with desired properties can be obtained only by static fermentation for 20-35 hours, preferably 21-32 hours, more preferably 26-30 hours, which greatly shortens the fermentation time in the traditional method.
<固液分离步骤><Solid-liquid separation step>
固液分离用于去除发酵时所产生物固体残渣,并回收发酵原液。固液分离可采用任何已知方法,包括但不限于离心、过滤、沉淀等。优选地,固液分离可采用离心分离方式,例如,采用离心机进行分离。离心的具体条件并不特别限定,可根据需要而适当调整。通过分离得到的发酵原液,即为葛根复合发酵物。Solid-liquid separation is used to remove the solid residue of the product produced during fermentation and recover the original fermentation liquid. Any known method can be used for solid-liquid separation, including but not limited to centrifugation, filtration, precipitation and the like. Preferably, the solid-liquid separation can be performed by centrifugation, for example, by using a centrifuge. The specific conditions of the centrifugation are not particularly limited, and can be appropriately adjusted according to needs. The fermentation stock solution obtained by separation is the kudzu root compound fermentation product.
本发明的第二方面,提供一种葛根复合发酵干粉的制备方法,采用上述制备方法获得葛根复合发酵物,然后将所述葛根复合发酵物进行浓缩干燥制得发酵干粉。干燥和/或浓缩步骤可用于除去培养基中小分子成分对于药效的影响。优选地,在干燥步骤之前包括浓缩步骤。通过浓缩和干燥可得到发酵粉。可以采用减压的方法进行浓缩和干燥,这里不再赘述。The second aspect of the present invention provides a method for preparing a kudzu root compound fermented dry powder. The above preparation method is used to obtain a kudzu root compound fermented product, and then the kudzu root compound fermented product is concentrated and dried to obtain a fermented dry powder. Drying and/or concentration steps can be used to remove the effects of small molecular components in the medium on drug efficacy. Preferably, a concentration step is included before the drying step. Baking powder is obtained by concentration and drying. Concentration and drying can be carried out by reducing pressure, which will not be repeated here.
本发明的第三方面,提供一种葛根复合发酵产品,其为通过本发明所述的制备方法制备得到的葛根复合发酵物或葛根复合发酵干粉。根据本发明的一个实施方式,所述发酵干粉的含水量低于5wt%,优选低于4.5wt%,超氧化物歧化酶SOD的活力大于等于420±5U/g,乳酸菌活菌数大于等于3.3±0.5×108CFU/g,葛根素含量大于5wt%。The third aspect of the present invention provides a kudzu root compound fermentation product, which is the kudzu root compound fermentation product or kudzu root compound fermentation dry powder prepared by the preparation method described in the present invention. According to one embodiment of the present invention, the water content of the fermented dry powder is lower than 5wt%, preferably lower than 4.5wt%, the activity of superoxide dismutase SOD is greater than or equal to 420±5U/g, and the number of viable lactic acid bacteria is greater than or equal to 3.3 ±0.5×10 8 CFU/g, and the puerarin content is greater than 5wt%.
本发明的第四方面,提供葛根复合发酵产品在制备具有抗腹泻作用的药物、食品或饲料添加剂中的用途。其中葛根复合发酵物在药物、食品或饲料添加剂中的添加量不特别限定。The fourth aspect of the present invention provides the use of kudzu root compound fermentation products in the preparation of medicines, food or feed additives with antidiarrheal effect. Wherein, the addition amount of the kudzu root compound fermented product in medicine, food or feed additive is not particularly limited.
作为药物的实例包括但不限于粉剂、丸剂固体剂型,还包括悬浮剂、混合剂、乳化剂等液体剂型。作为食品的实例包括但不限于糖果、饮料(如各类无醇饮料)、面包、饼干、酒以及各类保健品等。作为饲料的实例包括但不限于饲料添加剂。饲料添加剂是指在饲料生产加工、使用过程中添加的少量或微量物质,在饲料中用量很少但作用显著。Examples of drugs include, but are not limited to, solid dosage forms such as powders and pills, and liquid dosage forms such as suspensions, mixtures, and emulsifiers. Examples of food include but are not limited to candy, beverages (such as various non-alcoholic beverages), bread, biscuits, wine, and various health products. Examples of feed include, but are not limited to, feed additives. Feed additives refer to small or trace substances added during feed production, processing and use, which are used in small amounts but have significant effects in feed.
实施例1-葛根复合发酵物的制备方法The preparation method of embodiment 1-pueraria root compound fermentation product
1)粉碎:将葛根、黄芪和茯苓分别粉碎过药典2号筛,按葛根50重量份、黄芪35重量份和茯苓15重量份的比例将原料混合,然后加入10倍原料质量比的纯净水,制得悬浮液。1) Pulverization: Pueraria Radix, Radix Astragali and Poria Cocos are pulverized respectively No. 2 sieve of Pharmacopoeia, raw materials are mixed by the ratio of 50 parts by weight of Radix Puerariae, 35 parts by weight of Radix Astragali and 15 parts by weight of Poria Cocos, then add 10 times the pure water of raw material mass ratio, A suspension is prepared.
2)酶解液的制备:基于悬浮液的总重量,添加0.1wt%的果胶酶(活力单位50万U/g)、0.1wt%的纤维素酶(活力单位50万U/g)、0.1wt%的木聚糖酶(活力单位50万U/g)和胰蛋白酶的用量为0.1wt%(活力单位50万U/g)进行酶解。pH为6.8,温度为52℃,酶解时间为4.5h。2) Preparation of enzymatic solution: based on the total weight of the suspension, add 0.1wt% pectinase (activity unit 500,000 U/g), 0.1wt% cellulase (activity unit 500,000 U/g), 0.1 wt% xylanase (activity unit 500,000 U/g) and trypsin were used in an amount of 0.1 wt% (activity unit 500,000 U/g) for enzymolysis. The pH is 6.8, the temperature is 52°C, and the enzymatic hydrolysis time is 4.5h.
3)适量补加营养物质:酵母膏0.3wt%、硫酸铵1.5wt%、氯化锌0.05wt%、硫酸镁0.05wt%,磷酸二氢钾0.4wt%,发酵基质灭菌。3) Appropriate supplementation of nutrients: 0.3wt% of yeast extract, 1.5wt% of ammonium sulfate, 0.05wt% of zinc chloride, 0.05wt% of magnesium sulfate, 0.4wt% of potassium dihydrogen phosphate, and sterilization of the fermentation substrate.
4)接种和发酵:接种酵母菌3×107cfu/mL,28℃条件下,厌氧发酵16h,接种乳酸菌发酵剂5×106cfu/mL,然后在37℃条件下,静置发酵32h,最后维持温度为65℃,静置30h,进行发酵。4) Inoculation and fermentation: inoculate yeast 3×10 7 cfu/mL, anaerobically ferment at 28°C for 16 hours, inoculate lactic acid bacteria starter at 5×10 6 cfu/mL, and then ferment at 37°C for 32 hours , and finally maintain the temperature at 65° C., let stand for 30 hours, and carry out fermentation.
5)离心:发酵结束后进行离心处理,分离得到发酵物原液和固体残渣。发酵物原液即为葛根复合发酵物。5) Centrifugation: After the fermentation is finished, centrifugation is carried out to separate the fermented product stock solution and solid residue. The stock solution of the fermented product is the kudzu root compound fermented product.
实施例2-葛根复合发酵粉Embodiment 2- kudzu root compound fermentation powder
1)粉碎:将葛根、黄芪和茯苓分别粉碎过药典2号筛,按葛根50重量份、黄芪35重量份和茯苓15重量份的比例将原料混合,然后加入10倍原料质量比的纯净水,制得悬浮液。1) Pulverization: Pueraria Radix, Radix Astragali and Poria Cocos are pulverized respectively No. 2 sieve of Pharmacopoeia, raw materials are mixed by the ratio of 50 parts by weight of Radix Puerariae, 35 parts by weight of Radix Astragali and 15 parts by weight of Poria Cocos, then add 10 times the pure water of raw material mass ratio, A suspension is prepared.
2)酶解液的制备:添加0.1wt%的果胶酶(活力单位50万U/g)、0.1wt%的纤维素酶(活力单位50万U/g)、0.1wt%的木聚糖酶(活力单位50万U/g)和0.15wt%的胰蛋白酶(活力单位50万U/g)进行酶解。pH为6.8,温度为50℃,酶解时间为4.5h。2) Preparation of enzymatic solution: add 0.1wt% pectinase (activity unit 500,000 U/g), 0.1wt% cellulase (activity unit 500,000 U/g), 0.1wt% xylan Enzyme (activity unit 500,000 U/g) and 0.15 wt% trypsin (activity unit 500,000 U/g) were used for enzymolysis. The pH is 6.8, the temperature is 50°C, and the enzymatic hydrolysis time is 4.5h.
3)适量补加营养物质:酵母膏0.3wt%、硫酸铵1.5wt%、氯化锌0.05wt%、硫酸镁0.05wt%,磷酸二氢钾0.4wt%,发酵基质灭菌。3) Appropriate supplementation of nutrients: 0.3wt% of yeast extract, 1.5wt% of ammonium sulfate, 0.05wt% of zinc chloride, 0.05wt% of magnesium sulfate, 0.4wt% of potassium dihydrogen phosphate, and sterilization of the fermentation substrate.
4)接种和发酵:接种酵母菌6×107cfu/mL,28℃条件下,厌氧发酵16h,接种乳酸菌发酵剂8×106cfu/mL,然后在37℃条件下,静置发酵32h,最后维持温度为65℃,静置30h,进行发酵。4) Inoculation and fermentation: Inoculate yeast 6×10 7 cfu/mL, anaerobic fermentation at 28°C for 16 hours, inoculate lactic acid bacteria starter 8×10 6 cfu/mL, and then stand for fermentation at 37°C for 32 hours , and finally maintain the temperature at 65° C., let stand for 30 hours, and carry out fermentation.
5)离心:发酵结束后进行离心处理,分离得到发酵物原液和固体残渣;5) Centrifugation: After the fermentation is finished, centrifugation is carried out to separate and obtain the fermented product stock solution and solid residue;
6)浓缩:将分离后的发酵物原液进行减压浓缩,通过减压干燥得发酵粉,其中水含量为4wt%。6) Concentration: Concentrate the separated fermented material stock solution under reduced pressure, and dry under reduced pressure to obtain fermented powder, wherein the water content is 4 wt%.
实施例3-葛根复合发酵物饮料Embodiment 3- Pueraria root compound fermented beverage
将实施例1制得的葛根复合发酵物与水以1:6的重量比混合,添加15wt%蔗糖、0.5%wt柠檬酸,并进行均质-脱气-巴氏杀菌-灌装-冷却等步骤,可得到成品饮料。Mix the kudzu root compound fermented product prepared in Example 1 with water at a weight ratio of 1:6, add 15wt% sucrose, 0.5%wt citric acid, and perform homogenization-degassing-pasteurization-filling-cooling, etc. step, the finished beverage can be obtained.
实施例4-葛根复合发酵物酒Embodiment 4- Pueraria root composite fermented product wine
将实施例1制得的葛根复合发酵物与45度优质白酒、饮用水以1:8:4的重量比混合,并进行均质-脱气-巴氏杀菌-灌装-冷却等步骤,可得到葛根复合发酵物勾兑酒。The kudzu root compound fermentation product that embodiment 1 makes is mixed with 45 degree high-quality liquor, drinking water with the weight ratio of 1:8:4, and carry out the steps such as homogeneous-degassing-pasteurization-filling-cooling, can The kudzu root compound fermented product blended wine was obtained.
实施例5-发酵前后葛根素含量的变化The change of puerarin content before and after embodiment 5-fermentation
对照品溶液的制备:精密称取葛根素对照品适量,加30%乙醇制成每1ml含80μg的溶液,即得。Preparation of reference substance solution: Accurately weigh an appropriate amount of puerarin reference substance, add 30% ethanol to make a solution containing 80 μg per 1 ml, and obtain it.
供试品溶液的制备:Preparation of the test solution:
发酵物样品:称取实施例2的发酵粉0.35g(相当于葛根2.0g、黄芪1.4g和茯苓0.6g),精密称定,置具塞锥形瓶中,精密加入30%乙醇50ml,称定重量,加热回流30分钟,放冷,再称定重量,用30%乙醇补足减失的重量,摇匀,滤过,取续滤液1mL于10mL容量瓶中,用30%乙醇定容至刻度线,即得。Fermented product sample: take by weighing 0.35g of fermented powder of embodiment 2 (equivalent to 2.0g of kudzu root, 1.4g of astragalus and 0.6g of Poria cocos), accurately weighed, put in a stoppered Erlenmeyer flask, accurately add 50ml of 30% ethanol, weigh Determine the weight, heat to reflux for 30 minutes, let cool, then weigh again, make up the lost weight with 30% ethanol, shake well, filter, take 1mL of the filtrate in a 10mL volumetric flask, and dilute to the mark with 30% ethanol Line, that is.
水提液样品:取葛根2.0g、黄芪1.4g和茯苓0.6g,水浸泡30min,煎煮提取2次,每次加水量10倍量,每次提取时间2小时,过滤,滤液合并,浓缩至干粉,置具塞锥形瓶中,精密加入30%乙醇50ml,称定重量,加热回流30分钟,放冷,再称定重量,用30%乙醇补足减失的重量,摇匀,滤过,取续滤液1mL于10mL容量瓶中,用30%乙醇定容至刻度线,即得。Water extract sample: Take 2.0g of kudzu root, 1.4g of astragalus root and 0.6g of poria cocos, soak in water for 30min, decoct and extract twice, add 10 times the amount of water each time, extract for 2 hours each time, filter, combine the filtrates, and concentrate to Dry powder, put in a stoppered Erlenmeyer flask, accurately add 50ml of 30% ethanol, weigh, heat and reflux for 30 minutes, let cool, weigh again, make up the lost weight with 30% ethanol, shake well, filter, Take 1 mL of the continued filtrate in a 10 mL volumetric flask, and dilute to the mark with 30% ethanol to obtain the final product.
测定方法:test methods:
分别精密吸取对照品溶液与供试品溶液各10μl,注入液相色谱仪,测定,即得。色谱条件:流动相为甲醇和水(25:75),检测波长250nm,用30%乙醇溶液溶解对照品葛根素。色谱柱:Diamonsil C18柱(250mm×4.6mm,5μm),流速1.0mL/min,运行时间30min,进样量20μL。Precisely draw 10 μl each of the reference substance solution and the test solution, inject it into the liquid chromatograph, measure it, and obtain it. Chromatographic conditions: the mobile phase is methanol and water (25:75), the detection wavelength is 250nm, and the reference substance puerarin is dissolved in 30% ethanol solution. Chromatographic column: Diamonsil C18 column (250mm×4.6mm, 5μm), flow rate 1.0mL/min, running time 30min, injection volume 20μL.
表1发酵物样品与水提液样品葛根素含量的测定结果Table 1 Determination results of puerarin content in fermented product sample and water extract sample
实施例6-抗腹泻作用药效实验Embodiment 6-anti-diarrheal effect drug efficacy experiment
药物的制备:Preparation of the drug:
发酵粉:取实施例2制得发酵粉3.5g(相当于葛根20g原生药、黄芪14g原生药和茯苓6g原生药),加入蒸馏水定容至120ml,即得(按照小鼠灌胃体积20ml/kg计算体积)。Fermented powder: get 3.5g of fermented powder obtained in Example 2 (equivalent to the original drug of 20g of Pueraria Radix, 14g of Radix Astragali and 6g of Poria cocos), add distilled water and be settled to 120ml, to get final product (according to the volume of 20ml/ kg to calculate the volume).
水提液制备:取葛根20g,黄芪14g和茯苓6g,水浸泡30min,煎煮提取2次,每次加水量10倍量,每次提取时间2小时,过滤,滤液合并,旋旋转蒸发浓缩,用蒸馏水定容至120ml,即得。Preparation of water extract: Take 20g of kudzu root, 14g of astragalus and 6g of poria cocos, soak in water for 30min, decoct and extract twice, add 10 times the amount of water each time, extract for 2 hours each time, filter, combine the filtrates, and concentrate by rotary evaporation. Dilute to 120ml with distilled water, that is, too.
葛根提取液:取葛根40g,水浸泡30min,煎煮提取2次,每次加水量10倍量,每次提取时间2小时,过滤,滤液合并,旋旋转蒸发浓缩,用蒸馏水定容至120ml,即得。Pueraria root extract: Take 40g of Pueraria root, soak in water for 30min, decoct and extract twice, add 10 times the amount of water each time, and extract for 2 hours each time, filter, combine the filtrates, concentrate by rotary evaporation, and dilute to 120ml with distilled water, Instantly.
黄芪提取液:取黄芪40g,水浸泡30min,煎煮提取2次,每次加水量10倍量,每次提取时间2小时,过滤,滤液合并,旋旋转蒸发浓缩,用蒸馏水定容至120ml,即得。Astragalus extract: take 40g of Astragalus, soak in water for 30min, decoct and extract twice, add 10 times the amount of water each time, extract for 2 hours each time, filter, combine the filtrates, concentrate by rotary evaporation, and dilute to 120ml with distilled water, Instantly.
茯苓提取液:取茯苓40g,水浸泡30min,煎煮提取2次,每次加水量10倍量,每次提取时间2小时,过滤,滤液合并,旋旋转蒸发浓缩,用蒸馏水定容至120ml,即得。Poria cocos extract: take 40g Poria cocos, soak in water for 30min, decoct and extract twice, add 10 times the amount of water each time, extract for 2 hours each time, filter, combine the filtrates, concentrate by rotary evaporation, and distill the volume to 120ml with distilled water, Instantly.
番泻叶混悬液:临用前将干燥叶片(去叶脉),加入沸蒸馏水研和均匀后再加入冷蒸馏水配制成8%的番泻叶混悬液。Senna leaf suspension: before use, dry leaves (vein removed), add boiling distilled water to grind evenly, and then add cold distilled water to prepare 8% senna leaf suspension.
实验方法:experimental method:
取小鼠60只,雌雄各半,体重(20±2.0)g,随机分6组,每组10只,分别空白对照组,发酵粉、水提液组、葛根组,黄芪组和茯苓组,连续给药5d,分别灌胃给予对应药液,空白对照组给予同体积的生理盐水,末次给药前禁食12h后,给药1h后各组分别灌胃8%番泻叶混悬液0.3ml/只,分笼,每鼠一笼,笼下铺置吸水纸(滤纸),记录每次动物排便次数,观察以下各项指标,并统计分析。Take 60 mice, half male and half female, body weight (20 ± 2.0) g, randomly divided into 6 groups, 10 mice in each group, respectively blank control group, fermentation powder, water extract group, kudzu root group, astragalus group and Poria cocos group, Continuous administration for 5 days, each group was given the corresponding medicinal solution by intragastric administration, and the blank control group was given the same volume of normal saline. ml/only, divided into cages, one cage for each mouse, and absorbent paper (filter paper) was laid under the cage, and the number of defecation of each animal was recorded, and the following indicators were observed and statistically analyzed.
稀便率:每只动物排稀便数与总便数之比,以滤纸上每粒或每堆粪便为排便一次。Loose feces rate: the ratio of the number of loose feces discharged by each animal to the total number of feces, and each grain or pile of feces on the filter paper is regarded as one defecation.
稀便等级:以稀便污染滤纸面积直径(cm)定级,分为四级:1级(<10),2级(1~1.9),3级(2~3),4级(>3),统计时先逐个统计每一堆稀便的级数,然后将该鼠所有稀便级数相加,除以稀便次数得稀便的平均级数Loose stool grade: graded by the area diameter (cm) of the filter paper contaminated by loose stool, divided into four grades: grade 1 (<10), grade 2 (1-1.9), grade 3 (2-3), grade 4 (>3 ), when counting, first count the series of each pile of loose stools one by one, then add all the series of loose stools of the mouse, and divide by the number of loose stools to get the average series of loose stools
腹泻指数:稀便率与稀便平均等级的乘积。Diarrhea index: the product of the loose stool rate and the average grade of loose stool.
表2、抗腹泻实验结果 Table 2. Results of anti-diarrhea experiment
注:与空白组比较,*P<0.05**P<0.01;与发酵粉组比较,△P<0.05,△△P<0.01。Note: Compared with blank group, *P<0.05**P<0.01; compared with baking powder group, △P<0.05, △△P<0.01.
由实验数据统计结果可知,与空白组比较,发酵粉组、水提液组、葛根组、茯苓组的小鼠腹泻指数的显著性降低(P<0.01)。与发酵粉比较,水提液组、葛根组、茯苓组及黄芪组脾腹泻指数显著性降低(P<0.05)。这表明发酵粉组降低小鼠腹泻指数作用优于水提液组、葛根组、茯苓组及黄芪组。According to the statistical results of the experimental data, compared with the blank group, the diarrhea index of the mice in the fermentation powder group, the water extract group, the Pueraria root group and the Poria cocos group decreased significantly (P<0.01). Compared with the fermentation powder, the spleen diarrhea index of the water extract group, Pueraria root group, Poria cocos group and Astragalus group significantly decreased (P<0.05). This shows that the fermented powder group is better than the water extract group, kudzu root group, poria cocos group and astragalus group in reducing the diarrhea index of mice.
本发明并不限于上述实施方式,在不背离本发明的实质内容的情况下,本领域技术人员可以想到的任何变形、改进、替换均落入本发明的范围。The present invention is not limited to the above-mentioned embodiments. Without departing from the essence of the present invention, any deformation, improvement, and replacement conceivable by those skilled in the art fall within the scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810086336.2A CN108185140A (en) | 2018-01-30 | 2018-01-30 | Pueraria lobata composite fermentation object and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810086336.2A CN108185140A (en) | 2018-01-30 | 2018-01-30 | Pueraria lobata composite fermentation object and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108185140A true CN108185140A (en) | 2018-06-22 |
Family
ID=62591197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810086336.2A Pending CN108185140A (en) | 2018-01-30 | 2018-01-30 | Pueraria lobata composite fermentation object and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108185140A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111676168A (en) * | 2020-06-30 | 2020-09-18 | 大连澎立生物科技有限公司 | Nano-selenium detoxicant and preparation method thereof, detoxified biological protein selenium and preparation method and application thereof |
CN112450345A (en) * | 2020-12-10 | 2021-03-09 | 重庆伍六奇农业科技开发有限公司 | Radix puerariae fermented beverage capable of improving intestinal function and preparation method thereof |
CN115868630A (en) * | 2022-12-26 | 2023-03-31 | 山东金源中草药有限公司 | Plant functional beverage and preparation method thereof |
CN116616366A (en) * | 2023-05-31 | 2023-08-22 | 广州大台农饲料有限公司 | Fermented nutritional composition for improving lactation capacity of sows as well as preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104664270A (en) * | 2014-07-09 | 2015-06-03 | 普正药业股份有限公司 | Fresh and alive traditional Chinese medicine fruit-vegetable enzyme and preparation method thereof |
CN105962360A (en) * | 2016-05-09 | 2016-09-28 | 山东祥维斯生物科技股份有限公司 | Method for producing microorganism ferment |
CN106306512A (en) * | 2016-08-20 | 2017-01-11 | 裕龙农牧科技股份有限公司 | Fermented Chinese herbal medicine feed additive for treating porcine diarrhea |
-
2018
- 2018-01-30 CN CN201810086336.2A patent/CN108185140A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104664270A (en) * | 2014-07-09 | 2015-06-03 | 普正药业股份有限公司 | Fresh and alive traditional Chinese medicine fruit-vegetable enzyme and preparation method thereof |
CN105962360A (en) * | 2016-05-09 | 2016-09-28 | 山东祥维斯生物科技股份有限公司 | Method for producing microorganism ferment |
CN106306512A (en) * | 2016-08-20 | 2017-01-11 | 裕龙农牧科技股份有限公司 | Fermented Chinese herbal medicine feed additive for treating porcine diarrhea |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111676168A (en) * | 2020-06-30 | 2020-09-18 | 大连澎立生物科技有限公司 | Nano-selenium detoxicant and preparation method thereof, detoxified biological protein selenium and preparation method and application thereof |
CN111676168B (en) * | 2020-06-30 | 2022-01-25 | 大连澎立生物科技有限公司 | Nano-selenium detoxicant and preparation method thereof, detoxified biological protein selenium and preparation method and application thereof |
CN112450345A (en) * | 2020-12-10 | 2021-03-09 | 重庆伍六奇农业科技开发有限公司 | Radix puerariae fermented beverage capable of improving intestinal function and preparation method thereof |
CN115868630A (en) * | 2022-12-26 | 2023-03-31 | 山东金源中草药有限公司 | Plant functional beverage and preparation method thereof |
CN116616366A (en) * | 2023-05-31 | 2023-08-22 | 广州大台农饲料有限公司 | Fermented nutritional composition for improving lactation capacity of sows as well as preparation method and application thereof |
CN116616366B (en) * | 2023-05-31 | 2023-11-07 | 广州大台农饲料有限公司 | Fermented nutritional composition for improving lactation capacity of sows as well as preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102846674B (en) | Traditional Chinese drug microecology composition and preparation method thereof | |
CN102428832B (en) | A fungal drug substance with hypoglycemic effect and preparation method thereof | |
CN102669495B (en) | Wheat type piglet 14-35-days-old compound feed and preparation method thereof | |
CN102178100B (en) | Low-tryptophan feed for hybrid chicken and preparation method of the low-tryptophan feed | |
CN103734751B (en) | A kind of composite dietary and method for making thereof | |
CN108185140A (en) | Pueraria lobata composite fermentation object and its preparation method and application | |
CN106721803A (en) | A kind of selenium-rich health-care salicorne beverage | |
CN105614678A (en) | Selenium-rich salicornia nutrition and health care noodles and production technology thereof | |
CN103190547B (en) | Chinese herbal medicine feed additive for effectively controlling comprehensive respiratory diseases of pigs | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
CN103932180B (en) | A health food for relieving stress and anti-fatigue and its two-step fermentation preparation method | |
CN103976351A (en) | Health food capable of enhancing immunity and improving sleep and two-step fermentation preparation method thereof | |
CN107467456A (en) | A kind of nourshing kidney moistening lung sealwort Chinese angelica root health beverage and preparation method thereof | |
CN101491668A (en) | Composite with blood-sugar reducing function and preparation method thereof | |
CN106138900A (en) | Auxiliary treats hyperglycemia and the compositions of diabetic complication and application thereof | |
CN106260359A (en) | A kind of Saussurea involucrata culture compositions Ganoderma tea and preparation method thereof | |
CN108159162B (en) | Fermented product containing Magnolia officinalis raw material medicine and its preparation method and use | |
CN119113077B (en) | Composition for reducing blood sugar of plant components and preparation method and application thereof | |
CN108244638A (en) | Kalimeris fermentate and its preparation method and application | |
CN107810918A (en) | A kind of cultural method of No. two chickens in Plain | |
CN1218032C (en) | Ant fermentation wine and fermentation process thereof | |
CN101912439A (en) | Technology for extracting Chinese angelica and lightyellow sophora root | |
CN101491584A (en) | Combination with blood sugar reducing function and preparation method thereof | |
CN106361804A (en) | Traditional Chinese medicine composition for lowering blood sugar and manufacturing method thereof | |
CN113171436A (en) | Fructus amomi enzyme with stomach protection and/or anti-inflammatory functions and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180622 |